Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
Revenue
Arix Bioscience PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arix Bioscience PLC
LSE:ARIX
|
Revenue
£112k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Revenue
$2.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
3i Group PLC
LSE:III
|
Revenue
£4.7B
|
CAGR 3-Years
79%
|
CAGR 5-Years
28%
|
CAGR 10-Years
19%
|
|
Schroders PLC
LSE:SDR
|
Revenue
£2.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Revenue
£862.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
See Also
What is Arix Bioscience PLC's Revenue?
Revenue
112k
GBP
Based on the financial report for Dec 31, 2022, Arix Bioscience PLC's Revenue amounts to 112k GBP.
What is Arix Bioscience PLC's Revenue growth rate?
Revenue CAGR 5Y
-43%
Over the last year, the Revenue growth was -67%. The average annual Revenue growth rates for Arix Bioscience PLC have been -40% over the past three years , -43% over the past five years .